Pacific Biosciences
PACB
PACB
86 hedge funds and large institutions have $230M invested in Pacific Biosciences in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
29% less call options, than puts
Call options by funds: $512K | Put options by funds: $721K
Holders
86
Holding in Top 10
–
Calls
$512K
Puts
$721K
Top Buyers
| 1 | +$3.75M | |
| 2 | +$2.64M | |
| 3 | +$1.74M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.27M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.15M |
Top Sellers
| 1 | -$4.39M | |
| 2 | -$2.9M | |
| 3 | -$2.87M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.6M |
| 5 |
Morgan Stanley
New York
|
-$2.04M |